White kidney bean-based ingredient bears two health claims for weight loss and starch reduction.
Pacific Resources International (Sydney, Australia) is now the exclusive distributor of Phase 2, a carb-control ingredient from Pharmachem Laboratories (Kearny, NJ), in Australia and New Zealand.
Phase 2 is derived from an extract of white kidney bean, and it backed by two U.S. structure/function claims: one for starch reduction and the other for weight control. When taken just before a starchy meal, the ingredient has been shown to neutralize the digestive enzyme known as alpha amylase, temporarily delaying the digestion and absorption of carbohydrates. This delay allows a portion of the carbohydrates to pass through the digestive system before they can be converted into glucose, which reduces the caloric impact and lowering the glycemic index of the carbohydrates consumed.
Pacific Resources International was awarded the Phase 2 distributorship following its success in distributing Pharmachem’s StarchLite ingredient.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.